Global Health Catalyst (GHC) Summit

项目摘要 最近，来自美国和14个经济多样化国家的癌症政策领导人得出结论， 控制癌症的成功运动将越来越依赖于协调一致的国际合作， 合作。世界卫生组织最近的癌症报告强调了这方面的紧迫性。 国际合作，1400万新发癌症病例中超过60%，820万新发癌症病例中超过70% 低收入和中等收入国家（LMIC）每年发生的死亡人数，其中一些，可悲的是， 没有某种形式的合作，他们最没有能力对付癌症。这些重大 癌症死亡率的差异在某种程度上反映了辐射水平的深刻差异。 肿瘤科例如，超过50%的癌症治疗需要放射治疗 在非洲54个国家中，大约有一半的国家没有这种药物，初步研究表明， 实施放射治疗（如适用）的主要安全性问题。这个项目的总体目标是 一项提议是每年组织一次全球健康催化剂（GHC）癌症峰会， 美国和非洲机构之间的高影响力国际合作， 全球癌症负担日益增加，以及相关的差距。本次GHC峰会将在 回顾过去几年在以往举办的首脑会议上取得的成功和吸取的经验教训， 促进了合作，以支持非洲不同地区的癌症医疗机构， 国家，支持教育和培训工作，以建设人力/研究能力， 建立了富有成效的研究合作，沿着疾病预防和宣传 全球肿瘤学的项目。首脑会议的一个创新组成部分是注重外联 代表性不足的少数民族和资源丰富的非洲人在散居地的参与（AiD） 将人才流失的毁灭性影响转化为对抗癌症的收益。成果将包括： 并加强了美国和非洲机构合作伙伴的合作， 2010年，代表性不足的少数群体和散居国外者在全球 肿瘤学，由美国和非洲合作者共同撰写的同行评审出版物，联合 研究合作产生的专利，以及持续增长， 美国和非洲机构的参与，以应对日益增长的全球癌症负担 以及相关的差异。

Project Summary Recently, leaders in cancer policy from the USA and 14 economically diverse countries concluded that successful campaigns to control cancer will increasingly depend on concerted international collaborations. The recent World Health Organization Cancer Report highlights urgency for such international collaborations, with over 60% of 14 million new cancer cases and 70% of 8.2 million deaths per year occurring in low and middle income countries (LMIC), some of which, sadly, are the least capable of dealing with cancer without some form of collaboration. These major disparities in cancer deaths are in part a reflection of poignant underlying disparities in Radiation Oncology. For example, radiotherapy, which is needed in the treatment of over 50% of cancer patients, is not available in about half of Africa's 54 countries, and preliminary research shows major safety concerns in implementation of radiotherapy where available. The overall goal of this proposal is to organize yearly global health catalyst (GHC) cancer summits designed to catalyze high impact international collaborations between US and African Institutions to address the growing global burden of cancers, and associated disparities. This GHC summits, will build on the success and lessons learned over the past years during previously organized summits, that have catalyzed collaborations to support cancer healthcare institutions in different African countries, supported education and training efforts to build human/research capacity, and established fecund research collaborations, along with disease prevention and advocacy programs in global oncology. An innovative component of the summit is the focus on outreach engagement of under-represented minorities and the resource-laden Africans in Diaspora (AiD) to turn the devastating effects of brain drain to gain against cancer. Outcomes will include: new and strengthened collaborations involving partners from both USA and African institutions each year, significant increase in participation of under-represented minorities and diaspora in global oncology, peer-reviewed publications co-authored by both USA and African collaborators, joint patents resulting from research collaborations, and continuous growth to engage more participation from USA and African Institutions to address the growing global burden of cancer and associated disparities.